MedHelp®,the consumer division of Physicians Interactive®(PI) is expanding its diabetes management platform to allow individuals to track blood glucose levels on the Apple Watch®. With this new capability for consumers, MedHelp continues its focus on creating highly effective tools that help consumers, providers, payers and otherpartners address the management of chronic conditions that are rapidly taking a significant toll on America’s health and the national healthcare system.
A comprehensive platform for managing diabetes
Mindful of the notorious challenges in getting diabetes patients to actively manage their condition – an essential component of improving health outcomes – MedHelp’s robust platform is designed to encourage and enhance diabetes self-management.
With the release of MedHelp’s Sugar Sense app for Apple Watch, users can now display their glucose readings right from their wrists, helping them better understand their condition and stay within their blood glucose targets.
MedHelp’s diabetes management platform includes:
– Sugar Sense blood glucose tracking app on Android and iOS, and now watchOS 2 for Apple Watch
– Integration of Sugar Sense with Apple HealthKit™, enabling access to data shared by third parties and collected through the Apple Health app
– Data streaming from continuous glucose monitors, via HealthKit integration
– Integration with glucometers, smart scales, popular consumer wearables and other fitness and weight management devices
– Diabetes population health analytics
– Information and support through an extensive diabetes knowledge library and online support groups
“Half of all American adults have diabetes or prediabetes1, according to the most recent data, and one in every five healthcare dollars is now spent on diabetes care2,” said John de Souza, President of the Consumer Division of Physicians Interactive. “These stats are alarming and must be reversed. Deploying new tools that improve how we manage diabetes is a logical and important step – and MedHelp is dedicated to creating effective solutions for our partners on the front lines of battling the diabetes epidemic.”
